The numbers: Third-quarter profit rose 12% to $4.5 million, or $2.20 a share, as revenue climbed 7% to $25 million. Atrion's gross margin inched up from 51% to 52%, and its operating margin climbed from 25% to 26%. The company has an ideal financial position, with $19 million of cash and no debt.
The stock: Atrion soared 69% during the past year, beating major U.S. indices. The stock trades at a price-to-earnings ratio of 19, a discount to health care suppliers. The shares offer a 0.9% dividend yield.